Toll Free: 1-888-928-9744

Verisante Technology, Inc. (VRS) - Product Pipeline Analysis, 2016 Update

Published: Jun 15, 2016 | Pages: 32 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Verisante Technology, Inc. (Verisante), formerly T-Ray Science, Inc., carries out the development and commercialization of products for the early detection of all forms of skin cancer. The company's key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Verisante Technology, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Verisante Technology, Inc. Company Snapshot 6 Verisante Technology, Inc. Company Overview 6 Verisante Technology, Inc. Pipeline Products and Clinical Trials Overview 7 Verisante Technology, Inc. - Pipeline Analysis Overview 9 Business Description 9 Key Facts 9 Verisante Technology, Inc. - Major Products and Services 10 Verisante Technology, Inc. Pipeline Products by Development Stage 11 Verisante Technology, Inc. Pipeline Products Overview 13 ClearVu 13 ClearVu Product Overview 13 ClearVu Elite 14 ClearVu Elite Product Overview 14 Multispectral Imaging (MSI) System 15 Multispectral Imaging (MSI) System Product Overview 15 Verisante Aura 16 Verisante Aura Product Overview 16 Verisante Core - Cervical Cancer 17 Verisante Core - Cervical Cancer Product Overview 17 Verisante Core - Gastro-Intestinal Cancer 18 Verisante Core - Gastro-Intestinal Cancer Product Overview 18 Verisante Core - Lung Cancer 19 Verisante Core - Lung Cancer Product Overview 19 Verisante Core - Nasopharnygeal Cancer 20 Verisante Core - Nasopharnygeal Cancer Product Overview 20 Verisante Technology, Inc. - Key Competitors 21 Verisante Technology, Inc. - Key Employees 22 Verisante Technology, Inc. - Key Employee Biographies 23 Verisante Technology, Inc. - Locations And Subsidiaries 24 Head Office 24 Recent Developments 25 Verisante Technology, Inc., Recent Developments 25 Dec 21, 2015: Verisante Provides Operational Update 25 Jul 03, 2015: Verisante Provides Operational Update 25 Mar 12, 2015: Verisante Obtains Mexican Approval 26 Feb 18, 2015: Verisante Technology Announces Equipment Loan to Further Collaboration with Key Chinese Laboratory 26 Oct 01, 2014: Verisante Technology Announces Submission to the FDA for Aura, a Skin Cancer Detection Device 27 Jul 29, 2014: Verisante Technology Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board 27 Jun 10, 2014: Verisante Technology Partners with the BC Cancer Foundation to Showcase Aura for Skin Cancer Detection 28 Jun 02, 2014: Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update 28 May 13, 2014: Verisante Technology Announces Milestone Completion of Core Commercial Prototype for the Detection of Lung Cancer 29 Apr 30, 2014: Verisante Technology Announces 2013 Year End Results and Strategy for Direct Distribution 30 Appendix 32 Methodology 32 About GlobalData 32 Contact Us 32 Disclaimer 32
List of Tables
Verisante Technology, Inc. Pipeline Products and Clinical Trials Overview 7 Verisante Technology, Inc. Pipeline Products by Equipment Type 7 Verisante Technology, Inc. Pipeline Products by Indication 8 Verisante Technology, Inc., Key Facts 9 Verisante Technology, Inc., Major Products and Services 10 Verisante Technology, Inc. Number of Pipeline Products by Development Stage 11 Verisante Technology, Inc. Pipeline Products Summary by Development Stage 12 ClearVu - Product Status 13 ClearVu - Product Description 13 ClearVu Elite - Product Status 14 ClearVu Elite - Product Description 14 Multispectral Imaging (MSI) System - Product Status 15 Multispectral Imaging (MSI) System - Product Description 15 Verisante Aura - Product Status 16 Verisante Aura - Product Description 16 Verisante Core - Cervical Cancer - Product Status 17 Verisante Core - Cervical Cancer - Product Description 17 Verisante Core - Gastro-Intestinal Cancer - Product Status 18 Verisante Core - Gastro-Intestinal Cancer - Product Description 18 Verisante Core - Lung Cancer - Product Status 19 Verisante Core - Lung Cancer - Product Description 19 Verisante Core - Nasopharnygeal Cancer - Product Status 20 Verisante Core - Nasopharnygeal Cancer - Product Description 20 Verisante Technology, Inc., Key Employees 22 Verisante Technology, Inc., Key Employee Biographies 23


List of Figures
Verisante Technology, Inc. Pipeline Products by Equipment Type 8 Verisante Technology, Inc. Pipeline Products by Development Stage 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify